Dulaglutide Injection Suppliers & Bulk Manufacturers

Available Forms: Prefilled Pens

Available Strengths: 0.75 mg/0.5 mL,1.5 mg/0.5 mL, 3.0 mg/0.5 mL, 4.5 mg/0.5 mL

Reference Brands: Trulicity®(US & EU)

Category: Diabetes

Dulaglutide is a GLP-1 receptor agonist that enhances glucose-dependent insulin secretion, suppresses glucagon, and slows gastric emptying. Benefits include improved glycemic control in type 2 diabetes, weight reduction, and cardiovascular risk reduction in high-risk patients. Administered once weekly for convenience. Dulaglutide Injection is available in Prefilled Pens and strengths such as 0.75 mg/0.5 mL,1.5 mg/0.5 mL, 3.0 mg/0.5 mL, 4.5 mg/0.5 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Dulaglutide Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Dulaglutide Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Dulaglutide is manufactured under cGMP (FDA) and GMP (EMA) standards, ensuring quality across production. The FDA approves Trulicity® for T2DM with cardiovascular risk reduction, requiring post-marketing safety monitoring (e.g., pancreatitis, thyroid C-cell tumors). The EMA mandates similar vigilance, including risk minimization for medullary thyroid carcinoma. Both agencies require sterile manufacturing, stability testing (refrigerated storage; 14-day room-temperature stability post-opening), and batch traceability. FDA’s REMS is not required, but EMA emphasizes patient education on injection techniques. Non-compliance risks include regulatory actions (warning letters, recalls). For compliant global sourcing, refer PharmaTradz.com.